Skip to content

Clinical trials

Phase 4 Pulmonary Eosinophilia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Eosinophilia Phase: Phase 4 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20161
20183
20191
20203
20213
20221
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status5
Active, not recruiting2
Enrolling by invitation2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
GlaxoSmithKline2
Aristotle University Of Thessaloniki1
Azienda Ospedaliero Universitaria di Cagliari1
Bispebjerg Hospital1
Endeavor Health1
Hamamatsu University1
McMaster University1
NHS Greater Glasgow and Clyde1
Nantes University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Eosinophilia18
Asthma15
Lung Diseases3
Airway Remodeling1
Bronchial Diseases1
Chronic Disease1
Churg-Strauss Syndrome1
Eosinophilia1
Immune System Diseases1
Inflammation1

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.